Germline pathogenic or likely pathogenic variants (PVs) in the BRCA1 and BRCA2 (BRCA) genes increase the relative and absolute risks of breast, ovarian, and other cancers, such as prostate and pancreatic cancer (Garutti et al., 2023). The gene discussed is BRCA2; the disease is familial pancreatic carcinoma.